
Last update at 2026-06-04T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
MKKGY or STVN: Which Is the Better Value Stock Right Now?
Fri 25 Jul 25, 03:40 PMStevanato Group First Quarter 2025 Earnings: Beats Expectations
Sat 10 May 25, 01:38 PMStevanato Group (STVN) Q1 Earnings and Revenues Top Estimates
Thu 08 May 25, 11:50 AMStevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025
Thu 08 May 25, 10:37 AMSDZNY vs. STVN: Which Stock Should Value Investors Buy Now?
Tue 06 May 25, 03:40 PMHeron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates
Tue 06 May 25, 12:55 PMStevanato Group Full Year 2024 Earnings: In Line With Expectations
Fri 07 Mar 25, 11:23 AMQ4 2024 Stevanato Group SpA Earnings Call
Fri 07 Mar 25, 06:52 AMStevanato Group (STVN) Meets Q4 Earnings Estimates
Thu 06 Mar 25, 12:45 PMStevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024
Thu 06 Mar 25, 11:31 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | 187.60M | 165.70M | 96.28M | 54.71M |
| Minority interest | -0.16700M | 0.05M | -0.35500M | -0.05000M |
| Net income | 143.00M | 134.30M | 78.51M | 39.20M |
| Selling general administrative | 85.70M | 62.50M | 58.86M | 50.57M |
| Selling and marketing expenses | 26.10M | 20.40M | 20.04M | 26.14M |
| Gross profit | 319.80M | 265.40M | 194.18M | 138.02M |
| Reconciled depreciation | 64.82M | 56.38M | 54.10M | 46.22M |
| Ebit | 152.58M | 128.12M | 103.11M | 62.22M |
| Ebitda | 217.40M | 184.50M | 157.86M | 108.44M |
| Depreciation and amortization | 64.82M | 56.38M | 54.75M | 46.22M |
| Non operating income net other | - | - | - | - |
| Operating income | 152.58M | 128.12M | 103.11M | 62.22M |
| Other operating expenses | 791.30M | 681.60M | 558.93M | 474.32M |
| Interest expense | 29.80M | 18.80M | 5.99M | 5.61M |
| Tax provision | 44.60M | 31.40M | 17.68M | 16.01M |
| Interest income | 25.00M | 0.57M | 0.37M | 0.17M |
| Net interest income | -4.80000M | -4.51200M | -6.00900M | -5.99400M |
| Extraordinary items | - | - | - | - |
| Non recurring | - | - | - | - |
| Other items | - | - | - | - |
| Income tax expense | 44.60M | 31.40M | 17.68M | 16.01M |
| Total revenue | 983.70M | 843.90M | 662.04M | 536.54M |
| Total operating expenses | 127.40M | 103.10M | 91.07M | 75.80M |
| Cost of revenue | 663.90M | 578.50M | 467.86M | 398.52M |
| Total other income expense net | 35.02M | 37.58M | -6.83000M | -7.50600M |
| Discontinued operations | - | - | - | - |
| Net income from continuing ops | 143.00M | 134.27M | 78.60M | 38.71M |
| Net income applicable to common shares | 142.85M | 134.32M | 78.51M | 39.20M |
| Preferred stock and other adjustments | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 1659.47M | 1418.47M | 967.98M | 882.18M | 781.58M |
| Intangible assets | 32.16M | 31.93M | 33.90M | 34.82M | 34.51M |
| Earning assets | - | - | - | - | - |
| Other current assets | 6.35M | 0.44M | 0.00100M | 0.00100M | -0.00100M |
| Total liab | 663.79M | 577.18M | 657.84M | 616.74M | 550.18M |
| Total stockholder equity | 995.90M | 841.70M | 310.50M | 265.49M | 231.56M |
| Deferred long term liab | 4.63M | 7.33M | 10.13M | 9.10M | - |
| Other current liab | 111.94M | 88.70M | 75.15M | 50.15M | 51.72M |
| Common stock | 21.70M | 21.70M | 20.00M | 20.00M | 20.00M |
| Capital stock | 21.70M | 21.70M | 20.00M | 20.00M | 20.00M |
| Retained earnings | 26.00M | 27.00M | 355.61M | 287.33M | - |
| Other liab | 52.88M | 36.27M | 47.54M | 41.66M | - |
| Good will | 47.24M | 47.24M | 47.24M | 47.24M | 47.24M |
| Other assets | 2.59M | -0.40100M | 61.63M | 48.10M | 0.00100M |
| Cash | 228.74M | 411.04M | 115.60M | 85.39M | 74.52M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 462.50M | 338.62M | 316.18M | 262.94M | 243.91M |
| Current deferred revenue | 41.40M | 42.40M | 53.39M | 47.52M | 45.75M |
| Net debt | -10.37400M | -166.75300M | 247.41M | 290.28M | 242.56M |
| Short term debt | 69.96M | 42.73M | 68.89M | 70.23M | 54.66M |
| Short long term debt | 64.63M | 37.17M | 63.45M | 65.35M | 51.26M |
| Short long term debt total | 218.37M | 244.29M | 363.01M | 375.67M | 317.07M |
| Other stockholder equity | 116.62M | 106.95M | 78.51M | 39.20M | 41.41M |
| Property plant equipment | 660.69M | 415.41M | 339.04M | 306.93M | - |
| Total current assets | 845.77M | 865.97M | 492.77M | 449.58M | 394.88M |
| Long term investments | 1.83M | 1.97M | 3.51M | 4.61M | 4.74M |
| Net tangible assets | 921.36M | 770.23M | 239.48M | 192.53M | - |
| Short term investments | 27.91M | 27.17M | 41.52M | 40.88M | 40.14M |
| Net receivables | 369.48M | 278.42M | 195.84M | 190.70M | 181.04M |
| Long term debt | 133.75M | 183.99M | 273.94M | 284.18M | 245.19M |
| Inventory | 213.30M | 148.90M | 139.37M | 131.88M | 98.61M |
| Accounts payable | 239.20M | 164.80M | 118.74M | 95.05M | 91.77M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 831.58M | 686.05M | 211.98M | 206.29M | 170.15M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | 20.00M | 20.00M | 20.00M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | -0.01700M | 0.42M | 5.96M | 5.90M | 5.38M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 811.10M | 552.90M | 475.20M | 432.60M | 386.69M |
| Capital lease obligations | 19.98M | 23.13M | 25.62M | 26.14M | 20.63M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -243.00000M | 15.59M | -0.10000M | -0.63100M |
| Change to liabilities | 36.05M | 44.34M | 52.41M | 11.84M |
| Total cashflows from investing activities | -242.95000M | -96.42600M | -96.08900M | -74.33800M |
| Net borrowings | -31.03600M | -120.17700M | -17.07800M | 48.34M |
| Total cash from financing activities | -44.50000M | 254.80M | -26.51700M | 42.17M |
| Change to operating activities | - | - | - | - |
| Net income | 187.64M | 165.67M | 96.28M | 54.71M |
| Change in cash | -182.29900M | 295.44M | 30.21M | 10.87M |
| Begin period cash flow | 411.04M | 115.60M | 85.39M | 74.52M |
| End period cash flow | 228.74M | 411.04M | 115.60M | 85.39M |
| Total cash from operating activities | 103.30M | 133.30M | 155.66M | 42.57M |
| Issuance of capital stock | 0.00000M | 380.09M | - | - |
| Depreciation | 64.82M | 56.38M | 54.10M | 46.22M |
| Other cashflows from investing activities | - | - | - | - |
| Dividends paid | -13.50000M | -11.20000M | -8.90000M | -6.17000M |
| Change to inventory | -107.36700M | -31.20400M | -15.60300M | -42.67400M |
| Change to account receivables | -46.42400M | -54.76500M | -3.63100M | 5.87M |
| Sale purchase of stock | - | 8.00M | - | - |
| Other cashflows from financing activities | 13.24M | 6.13M | 51.37M | 102.25M |
| Change to netincome | 13.42M | -14.79200M | -10.13800M | -17.87400M |
| Capital expenditures | 243.13M | 113.18M | 96.00M | 73.91M |
| Change receivables | - | - | - | - |
| Cash flows other operating | - | - | - | - |
| Exchange rate changes | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - |
| Change in working capital | -117.73900M | -41.63200M | 33.18M | -24.97200M |
| Stock based compensation | - | - | - | - |
| Other non cash items | -31.42500M | -47.12300M | -27.90400M | -33.38700M |
| Free cash flow | -139.82700M | 20.12M | 59.65M | -31.33400M |
Sector: Healthcare Industry: Medical Instruments & Supplies
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| STVN Stevanato Group SpA |
-0.02 0.11% | 18.51 | 44.69 | 40.49 | 7.09 | 6.24 | 7.33 | 28.26 |
| ISRG Intuitive Surgical Inc |
11.53 2.83% | 418.82 | 73.05 | 61.73 | 19.15 | 10.25 | 18.41 | 59.92 |
| ESLOF EssilorLuxottica Société anonyme |
- -% | 201.48 | 44.84 | 27.62 | 4.07 | 2.49 | 3.71 | 16.04 |
| ESLOY Essilor International SA |
4.49 4.57% | 102.66 | 41.68 | 27.25 | 3.94 | 2.45 | 3.71 | 16.04 |
| BDX Becton Dickinson and Company |
3.95 2.71% | 149.56 | 25.56 | 12.48 | 2.59 | 1.76 | 2.89 | 12.55 |
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for biopharma and healthcare. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Via Molinella, 17, Piombino Dese, PD, Italy, 35017
| Name | Title | Year Born |
|---|---|---|
| Mr. Franco Stevanato | Exec. Chairman | 1973 |
| Mr. Franco Moro | CEO, COO & Director | 1963 |
| Mr. Marco Dal Lago | Chief Financial Officer | 1972 |
| Mr. Paolo Patri | Chief Technology Officer | 1970 |
| Ms. Lisa Miles | Sr. VP of Investor Relations | NA |
| Mr. Mauro Stocchi | Chief Bus. Officer | 1966 |
| Mr. Riccardo Butta | Pres of Americas | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.